Preliminary observations indicate that Selenium (Se) tested on GBM cells resistant to Docetaxel (DTX) may improve the apoptotic efficacy of DTX through the activation of TRPM2 by oxidative stress (Ertilav et al., 2019). The gene discussed is TRPM2; the disease is glioblastoma.